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Clinical profile and outcome of patients
with cardiac myxomas treated surgically. 
A 20-year experience with long-term follow-up
Marek Jemielity, Bart∏omiej Perek, S∏awomir Katarzyƒski, 
Marcin Misterski, Wojciech Dyszkiewicz
I n t r o d u c t i o n.  Primary neoplasms of the heart are very rare, benign cardiac myxomas being the most common. The aim
of this study was to present the clinical profile and long-term outcome of patients (pts) who underwent surgical resection of
cardiac myxoma. 
M a t e r i a l  a n d  m e t h o d s.  Between 1981 and 2000, 21 pts (12 female and 9 male), mean age 43.9 ± 14.5 years
(range:21-74 yrs) underwent surgery for cardiac myxoma. Before surgery we performed physical examination, ECG, chest X-
ray, echocardiography (M + 2D) and coronary artery angiography (in patients over 40 years of age). All pts were operated by
median sternotomy in moderate hypothermia (26-28°C) with the use of cardiopulmonary bypass. At the end of the follow up
clinical examination and echocardiography (M + 2D) were performed.
R e s u l t s.  Before operation 19 pts (90.5%) presented with cardiac signs related to mitral orifice obstruction. Six of them
(28.6%) were NYHA class II, 8 (38.1%) - class III and 5 (23.8%) - class IV. Events of embolism occurred in 6 pts (28.6%).
Ten pts (47.6%) had nonspecific systemic or constitutional symptoms, including permanent fever and significant weight loss.
Two pts (9.5%) were asymptomatic, diagnosis being established accidentally. In all cases definite diagnosis was made by
echocardiography. The myxomas were located in the left atrium in 18 pts (85.7%), in the right atrium in 2 pts (9.6%) and in
the right ventricle in one pt (4.7%). One pt (4.7%) died in hospital because of low cardiac output syndrome and, eventually,
multiorgan failure. The mean follow up of 5.4 ± 4.0 years (range: 3 mos - 20 yrs) was completed by all pts. Two pts died during
follow up for noncardiac-related reasons. The cumulative survival rate calculated from the Kaplan-Meier curve was 85.2% after
5 years. No tumor recurrences were observed. At the end of follow up all pts were in NYHA class I or II.
C o n c l u s i o n s.  Most preoperative symptoms of heart myxomas are related to mitral valve obstruction. The final diagnosis
can be made by echocardiography. Surgical resection is a safe and curative therapy with a low risk of recurrence.
Przebieg kliniczny i wyniki leczenia chirurgicznego 
u chorych ze Êluzakami serca – 20 lat doÊwiadczeƒ
W s t ´ p.  Pierwotne nowotwory serca nale˝à do rzadkoÊci. PoÊród nich ∏agodne Êluzaki sà najcz´stszymi pierwotnymi guza
serca. Celem pracy by∏o przedstawienie charakterystyki klinicznej i ocena odleg∏ych wyników leczenia chorych operowanych
z powodu Êluzaków serca.
C h o r z y  i  m e t o d a.  Od 1981 r. do 2000 r. operowano 21 chorych (12 kobiet i 9 m´˝czyzn), w wieku od 21 do 74 lat (Êrednio
43,9±14,5 lat). Przed operacjà chorych poddano badaniu fizykalnemu, wykonano badanie EKG, zdj´cie radiologiczne
klatki piersiowej, echokardiografi´ (M + 2D) i koronografi´ (u chorych powy˝ej 40 lat). Wszystkich operowano  ze sternotomii
poÊrodkowej w umiarkowanej hipotermii (26-28°C), z u˝yciem krà˝enia pozaustrojowego. Podczas ostatniej obserwacji
odleg∏ej oceniano stan kliniczny i ponownie wykonano echokardiografi´ (M + 2D).
W y n i k i.  Przed operacjà u 19 chorych (90,5%) stwierdzano objawy typowe dla zw´˝enia lewego ujÊcia ˝ylnego. SzeÊciu
spoÊród nich (28,6%) znajdowa∏o si´ w II klasie wydolnoÊci wed∏ug Nowojorskiego Towarzystwa Kardiologicznego (NYKA),
8 chorych (38,1%) w klasie III i 5 (23,8%) w klasie IV. Epizody zatorowe przed operacjà obserwowano u 6 chorych (28,6%).
Dziesi´ciu chorych (47,6%) prezentowa∏o niespecyficzne objawy  ogólne, w tym przewlek∏e goràczki i znacznà utrat´ masy cia∏a.
Dwóch chorych (9,5%) by∏o bezobjawowych przed operacjà. We wszystkich przypadkach ostateczne rozpoznanie stawiano na
podstawie badania echokardiograficznego. Âluzaki lokalizowano w lewym przedsionku u 18 chorych (85,7%), w prawym
przedsionku u 2 (9,6%) i w prawej komorze u 1 (4,7%). Jeden  chory (4,7%) zmar∏ w szpitalu z powodu zespo∏u niskiego rzutu
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Introduction
Primary heart tumors are very rare and account for less
than 0.1% of all neoplasms [1]. Approximately 75% of
them are benign [2]. Cardiac myxoma is the most com-
mon lesion and accounts for more than 80% of primary
benign cardiac tumors [2, 3]. Other, extremely rare tu-
mours are: rhabdomyoma, fibroma, lipoma and benign te-
ratoma. Before the development and introduction of an-
giocardiography and echocardiography heart neoplasms
were diagnosed mainly post mortem. Myxomas may re-
semble many cardiovascular or systemic diseases, and can
be found in any of the cardiac chambers, although a ma-
jority arises from the septum of the left atrium [4]. Nowa-
days most cases of myxomas (even small one) can be de-
tected in living patients utilizing noninvasive techniques
[5]. Surgical resection is a method of choice, considered to
be complete and curative therapy [6]. The first successful
removal of cardiac myxoma was performed by Crafoord
in 1954 (7). Since then a variety of approaches have been
developed, including an isolated left or right atriotomy, ri-
ght atriotomy with transseptal incision and biatrial techni-
que [8, 9].
The aim of this study was to present our experiences
gathered over a 20-year period. We report the clinical
profiles and long-term outcomes of patients who had un-
dergone surgical resection of cardiac myxomas.
Material and methods
Pa t i e n t s
Between 1981 and 2000, 21 patients (12 female and 9 male) un-
derwent cardiac myxoma resection at the Cardiac Surgery De-
partment of The Karol Marcinkowski University of Medical
Sciences in Poznan, Poland. Patient age ranged from 21 to 74
years (mean: 43.9 ± 14.6 years).
P r e o p e r a t i v e  e x a m i n a t i o n
Before surgery historical review and physical examination were
performed and clinical status according to NYHA functional
classification was assessed. Chest X-ray (postero-anterior and si-
de projections), ECG, cross sectional echocardiography and co-
ronary artery angiography (in patients over 40 years of age) we-
re carried out. In echocardiography the size of tumor and the fol-
lowing parameters were assessed: aortic root diameter (Ao),
left ventricle end-diastolic dimension (LVED), left atrium di-
mension (LA), right ventricle dimension (RV), ventricular sep-
tum dimension (IVS), left ventricle posterior wall dimension
(LVPW).
O p e r a t i o n
In each patient documentation of atrial myxoma prompted
urgent operative intervention. All patients were operated with
the use of routine cardiopulmonary bypass (CPB). After me-
dian sternotomy CPB was installed with aortic and bicaval veno-
us cannulation. During insertion of venous cannulas care was ta-
ken to minimize manipulation of the heart to avoid tumor embo-
lization. Moderate systemic hypothermia (26° to 28°C) was
employed. Topical cooling with cold saline and continuous ante-
grade infusion of hyperkalemic crystalloid cardioplegia (St.Tho-
mas II formula) were used to induce and maintain cardiac arrest.
After the aorta was cross-clamped, right atriotomy was perfor-
med and the right atrium and ventricle were explored. If the
myxoma was located in the left atrium, interatrial septum was cut
down. Tumors attached to the interatrial septum were resected
with the pedicle and a full-thickness portion of the adjacent inte-
ratrial septum (en bloc resection). The surgically created atrial
septal defect was closed primarily in 18 patients and with a peri-
cardial patch in one. Tumors arising from free atrial and ventri-
cular wall were excised with the rim of at least 5 mm of the endo-
cardium and myocardium. The mitral valve was checked for va-
lvular damages or incompetence caused by annular dilatation
secondary to the myxoma. All resected tumors were examined
histologically.
Fo l l o w  u p  e x a m i n a t i o n
At the end of follow up the clinical examination and echocardio-
graphy (M + 2D) were performed. NYHA functional class was
reassessed. In transthoracic echocardiography the heart was in-
spected for tumor recurrence and the same parameters as befo-
re operation were measured again.
D a t a  m a n a g e m e n t
All continuous variables are expressed as mean ±standard devia-
tion. Differences between continuous variables (pre- vs. postope-
rative Ao, LVED, LA, RV, IVS, LVPW) were evaluated by t test,
between categorical variable (pre- vs. postoperative NYHA) by
chi-square or Fisher exact test. A probability value of p < 0.05
was considered significant. The cumulative survival rate was cal-
culated using the Kaplan-Meier method. Statistica 5.0 for Win-
dows was used for statistical analyses.
Results
P r e o p e r a t i v e  c l i n i c a l  p r o f i l e
Before operation, 19 patients (90.5%) presented with
cardiac signs. Among them, the most common progressi-
ve congestive cardiac failure (varied from easy fati-
gue to dyspnea at rest) was present in 14 cases (66.7%),
palpitations in 7 (33.3%) and acute heart failure with
pulmonary edema in 2 (9.5%). Six of them (28.6%) were
serca. Wszyscy chorzy znaleêli si´ w obserwacji odleg∏ej, która wynios∏a 5,4±4,0 lat (od 3 miesi´cy do 20 lat). Dwóch
chorych zmar∏o w okresie obserwacji odleg∏ej z przyczyn nie kardiologicznych. Prawdopodobieƒstwo prze˝ycia po 5 latach od
zabiegu, wyliczone z krzywej Kaplan-Meier'a, wynios∏o 85,2%. Nie zanotowano nawrotów guza. Podczas ostatniej obserwacji
odleg∏ej wszyscy chorzy znaleêli si´ w I lub II klasie wg NYHA.
W n i o s k i.  Objawy zw´˝enia lewego ujÊcia ˝ylnego dominujà w obrazie klinicznym u chorych ze Êluzakami serca. Ostateczne
rozpoznanie stawia si´ na podstawie echokardiografii. Zabieg chirurgiczny jest bezpieczny, obarczony niewielkim ryzykiem
wznowy i zapewnia wyleczenie.
Key words: cardiac myxoma, clinical presentation, surgery
S∏owa kluczowe: Êluzaki serca, objawy kliniczne, leczenie chirurgiczne
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found in functional NYHA class II, 8 (38.1%) in class III
and 5 (23.8%) in class IV (Figure 1). One patient with
a right atrial myxoma had peripheral edema. Events of
embolism occurred in 6 patients (28.6%). Embolic lo-
cations were the central nervous system (4 patients) and
the upper or lower extremities (2 patients). Ten patients
(47.6%) had nonspecific systemic or constitutional symp-
toms, including permanent fever (in 7 cases) and signifi-
cant weight loss (over 10 kg within the last 6 months
prior to diagnosis and surgery) (in 8 cases). Two patients
(9.5%) were asymptomatic and diagnosis was establi-
shed accidentally. In routine chest X-ray radiographic
evidence of left atrium enlargement were observed.
In our group the time interval between the clinical
symptoms onset and the final diagnosis varied between 3
and 166 months.
Electrocardiographic findings included left atrial hy-
pertrophy (6 patients), nonspecific ST-segment abnor-
malities (5 patients) and premature atrial beats (2 pa-
tients). All patients were in normal sinus rhythm. Chest
radiograms were abnormal in 12 patients (57.1%). Pulmo-
nary edema (2 cases), interstitial markings or chronic
congestive heart failure signs (7 cases) and left atrial en-
largement (9 cases) were observed. In all cases the defini-
te diagnosis was made by transthoracic or transesophage-
al (after 1995) echocardiography. The tumor was loca-
ted in the left atrium in 18 patients (85.7%), in the right
atrium in two patients (9.6%) and in the right ventricle in
one (4.7%). The size of tumor calculated from 2-dimen-
sional echocardiograms varied between 3.5 x 3 cm to the
8.1x 3.5 cm. Coronary arteriography did not show any si-
gnificant changes, therefore no patient required additio-
nal bypass surgery.
O p e r a t i v e  f i n d i n g s
During operation cardiac myxomas were at the locali-
zation indicated by preoperative echocardiography. The
tumors found in the left atrium were attached to the inte-
ratrial septum in 17 and to the posterior wall in 1 pa-
tient. In one case the large, pedunculed tumor arising
from the atrial septum, prolapsed to the left ventricle
through mitral valve. Although the valve was obstructed
prior to surgery, the mitral valvular apparatus was in-
tact and after tumor resection the valve was neither in-
competent nor stenotic. In the right atrium two myxomas
arose from the septum. Right ventricular myxoma was at-
tached to the free wall 2 cm below the tricuspid valve.
The size of tumor assessed intraoperatively varied from 3
cm to 7 cm. The mean weight of the tumors was 32 ± 5
g (ranged from 14 to 95 g). The majority of them were
pedunculated with a short stalk (<1 cm) (n=16, 76.2%),
white the others were sessile-based. The myxoma with
smooth surface was noted in 15 patients (71.4%) and
with villous or papillary one in the others (28.6%). The
friable villous-surface cardiac myxomas had a tendency to
fragment easily, so special attention was paid to remove
them as the entire tumors. All the patients had the tumor
removed completely and all excisional margins showed
no microscopic evidence of tumor. Histological examina-
tion revealed myxoma in all the cases, with microscopic
calcifications in 33.3% (7 patients). The characteristic
myxoma cells containing pink eosinophilic cytoplasm and
ovoid nucleus were embedded in amorphous myxoid ma-
trix. In 16 patients (76.2%) these cells surrounded nume-
rous vessels.
I n - h o s p i t a l  r e s u l t s
In our series there was one in-hospital death (4.8%).
A 52-year old male patient died three days after surgery,
because of low cardiac output syndrome and, eventually,
multiorgan failure. He had pulmonary edema at admis-
sion to hospital. Very soon he developed cardiogenic
shock. He had to be intubated prior to operation due to
respiratory failure. Surgical intervention was performed
urgently. His mitral valve was occluded by the huge tu-
mor (as described above). Soon after operation an in-
traaortic balloon pump was employed, but the patient
did not manage to recover and died three days later. No-
body required reoperation in the early postoperative pe-
riod.
Postoperative organ complications occurred in five
patients (23.8%). Two of the patients had atrial fibrillation
treated with antiarhythmic drugs. The other two had evi-
dence of significant pleural effusion, which was successful-
ly evacuated by pleural puncture. One patient developed
pneumonia and was referred to pulmonary disease de-
partment, where he stayed three weeks and then was di-
scharged from hospital in a good overall condition. We
observed neither organ (neurologic, renal etc.) nor surgi-
cal complications.
The mean in-hospital stay was 10.2 ± 3.3 days (ran-
ge: 6 -14 days). All patients were discharged from hospi-
tal in stable condition.
Fo l l o w - u p  e x a m i n a t i o n
The follow up ranging between 3 months and 20 years
(mean 5.4 ± 4.0 years) was complete. During follow up
two non cardiac-related deaths occurred. One 78-year
old female patient died 18 years after surgery, because of
breast cancer. The other, a 56 year old man with coexi-
sting malignant colon tumor, died 15 months after surge-
ry. The cumulative survival rate calculated from the Ka-
plan-Meier curve was 85.2% after 5 years (Figure 2). Du-
ring follow up, three patients required cardiac-related
hospitalization. In one case sick sinus syndrome was dia-
gnosed four years after tumor resection and the patient
underwent uneventful permanent pacemaker implanta-
tion. The others had rhythm disturbances (atrial fibrilla-
tion), but treated medically.
At the end of follow up, all patients were in functio-
nal NYHA classes I or II (Figure 1).
Up to now no echocardiographic evidence of the tu-
mor recurrence has been noted. The dimensions of the
cardiac chambers did not change as compared to the pre-
operative state (Table I).
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Discussion
Although the clinical manifestation of cardiac myxomas
are not typical, some authors outline three following ma-
in patterns of presentation: cardiac, embolic and systemic
[1, 4]. Cardiac symptoms (dyspnea, dizziness, progressive
congestive heart failure and palpitation) associated with
mitral valve obstruction are the most frequent [8, 9, 10].
The floating tumors render blood flow from the pulmona-
ry veins to the left atrium difficult and moving in the dia-
stole in the direction of the mitral valve cause syncope,
acute pulmonary edema and even sudden cardiac death
[4]. The gelatinous and fragile tumors are sources of em-
bolic material, therefore both permanent or transient
embolic complications (to central nervous system, corona-
ry arteries, extremities and kidney) are observed in aro-
und 20-30% [8, 9]. In one recent report 80% of the myxo-
ma cases were admitted to hospital with stroke or tran-
sient ischemic attacks [23]. The third pattern comprises
constitutional symptoms and signs of generalized illness li-
ke fatigue, muscle weakness, loss of body mass, perma-
nent fever and arthralgia [1, 4]. This is probably caused by
proinflammatory interleukin-6 produced and secreted by
some myxoma cells [11]. In our series, cardiac symptoms
of mital valve obstruction dominated and were presented
by all symptomatic patients. More than two-thirds of
thromboembolic complications affected the central ne-
rvous system, thus proving earlier observations [8, 12].
Approximately 70% to 80% are found in left atrium,
10% to 20% are in the right atrium, and less than 10%
are in both atria or either ventricle [4, 8, 9]. Atrial myxo-
mas usually arise from the interatrial septum in the area
of fossa ovalis, but they can also be found at the free wall
of the atrium [8, 13]. In our series only one tumor was at-
tached to the free atrial wall, that is less than observed by
the others [19]. In rare instances they may have multiple
foci and can involve mitral valvular tissue [12, 14].
Among examinations routine ECG and chest X-ray,
as nonspecific, are unlikely to suggest the diagnosis of
myxoma [1]. ECG findings are: nonspecific ST changes,
left atrial hypertrophy or premature atrial complexes [4,
8]. It is estimated that at least one-third of the patients
had normal ECG [4]. The results of earlier reports were
thus confirmed. We did not find any ECG changes in
more than 50% of patients and the most common fin-
dings were signs of left atrial hypertrophy and ST changes.
On chest X-rays of some patients nonspecific cardiomega-
ly (including left atrial enlargement) could be seen, as in
our two asymptomatic patients, and intensified pulmo-
nary vascularity was observed [4]. In rare instances pulmo-
nary edema secondary to severe mitral valve obstruction
is noted. Calcifications making the tumor visible and pleu-
ral effusion are unusual [1, 8]. Echocardiographic exa-
mination is usually the method of choice and in more
than 95% of cases definite diagnosis is possible [5, 8]. It
allows to determine localization and size even of small tu-
mors, the site of attachment and presence of any myxoma
prolapse [9, 12]. An introduction of transesophageal echo-
cardiography increased the sensitivity of this diagnostic to-
ol. In our group cross sectional echocardiography allo-
wed to establish the final diagnosis in all cases, to localize
adequately the tumor site and to calculate the approxima-
te size. The hemodynamic examination is recommended
when tumors are atypically located especially inside the
ventricles or there are some others diagnostic doubts.
During cardiac catheterization, measurements of pulmo-
nary artery pressure are enabled [8]. Moreover, coronary
arteriography is recommended in all patients aged over 40
years undergoing cardiac procedures. Computer tomo-
graphy and magnetic resonance are also very helpful [4].
Some authors reported incidental diagnosis made during
Figure 1. NYHA functional class before operation and at the end of
follow up
Figure 2. Cumulative survival rate calculated using Kaplan-Meier
curve 5 years after tumor resection
Table I. Echocardiographic parameters prior to surgery and at the end
of follow up
before operation end of follow up p value
Ao [mm] 29.7±2.3 30.1±2.7 0.54*
LVED [mm] 47.1±6.4 47.5±5.1 0.81*
LA [mm] 45.8±9.1 44.4±7.5 0.42*
RV [mm] 24.9±4.9 24.9±3.5 0.95*
IVS [mm] 10.7±1.3 10.7±1.2 0.84*
LVPW [mm] 10.6±1.2 10.3±1.3 0.63*
* ns (no statistically significant difference)
Ao - aorttic root diameter, LVED - left ventricle end-diastolic dimen-
sion, LA - left atrium dimension, RV - right ventricle dimension, IVS -
ventricular septum dimension, LVPW - left ventricle posterior wall di-
mension
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cardiac surgery for mitral stenosis, but it was before the
introduction of transesophageal which is echocardiogra-
phy useful in some difficult cases [1, 10].
In general, patients benefit from surgical correction,
which is considered to be curative treatment [1, 10]. Like-
wise in our group, most patients in reviewed studies were
found in functional NYHA classes I and II after operation
[1, 8]. The most frequent postoperative complications
are arrhythmias, including supraventricular rhythm di-
sturbances or atrial fibrillation [1, 4, 12]. In our series
atrial fibrillation occurred in two patients in the early po-
stoperative period and in two other patients during follow
up. Exceptional permanent cardiac pacemaker implan-
tation is necessary [1, 4]. During follow-up thromboembo-
lic events, mainly related to atrial fibrillation are reported
[9, 12].
The rate of cardiac myxoma recurrence is 4% to 5%
[8, 15]. It usually happens within 5 years after the opera-
tion [16]. It can be a result of inadequate resection, espe-
cially in patients with multifocal familial myxomas, or in-
traoperative implantation or transformation from benign
to malignant lesion [1, 8]. In order to avoid it we inspected
heart chambers very carefully and special attention was
paid not to manipulate the heart and the tumor during
the operation. Moreover, none of our patients had fami-
lial myxoma, which may partially explain no cases of re-
currence. Also, histological type can influence the recur-
rence rate [4]. Pinede et al. observed the recurrences on-
ly in patients with active and poorly differentiated forms.
They distinguished active with a dense myxoma cells from
inactive with a sparse, sometimes calcified, cell infiltrate
and normally differentiated with numerous rudimentary
or well-formed vessels surrounded successively by cells
then by condensed matrix from poorly differentiated with
many isolated, dispersed cells or lepidic cells gathered in
short chains throughout the matrix [4]. In our group of
patients the majority of myxomas were normally diffe-
rentiated and inactive - characterized by a very low proba-
bility of recurrence. Some authors suggested that although
cardiac myxomas were usually considered benign, yet
they might have an intrinsic malignant potential (docu-
mented recurrences, multicentricity and distant metasta-
ses) [17]. It has been proposed recently that recurrent
tumors represent an intrinsically more aggressive sub-
group that produced high levels of IL-6 [18].
Conclusions
Basing on 20 years of experience we can conclude that
a majority of preoperative symptoms of heart myxomas
are related to mitral valve obstruction. The final diagno-
sis can be made by cross sectional echocardiography. Sur-
gical resection is a safe and curative therapy with a low re-
currence risk.
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